Analysis by Dr. Joseph Mercola STORY AT-A-GLANCE April 30, 2019, the U.S. Food and Drug Administration (FDA) announced it will require sedative-hypnotics — a class of sleep medication used to treat insomnia — to carry a black box warning stating drug side effects may include dangerous behaviors done while sleeping, such as eating, walking, driving or engaging in a range of activities in your sleep that can lead to injury or death These potentially dangerous behaviors are more common with eszopiclone (Lunesta), zaleplon (Sonata), and zolpidem (Ambien, Ambien CR, Edluar, Intermezzo, Zolpimist) than other prescription sleep aids Over the past 26
[More]